Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peritoneal dialysis in Mexico.

Alfonso M Cueto-Manzano1

  • 1Unidad de Investigación Médica en Epidemiología Clínica, Hospital de Especialidades, CMNO, IMSS, Guadalajara, Mexico. a_cueto_manzano@hotmail.com

Kidney International. Supplement
|July 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Change in dietary and lifestyle habits and its relationship with body mass index after kidney transplantation.

Clinical nutrition ESPEN·2025
Same author

Early Detection of Chronic Kidney Disease in Mexico, a Case for Policy Transfer.

Risk management and healthcare policy·2025
Same author

Predictors of vitamin D concentration in chronic dialysis patients from Mexico.

Salud publica de Mexico·2025
Same author

Kidney Disease in Latin America: The Hottest Spot on the Globe.

Seminars in nephrology·2025
Same author

Kidney Health Programs in Latin America: Results of the SLANH Survey 2024.

Seminars in nephrology·2025
Same author

Kidney Function in the Wixarika (Huichol) Ethnic Group, a Disadvantaged Population Underevaluated in Mexico.

Kidney medicine·2025
Same journal

Effect of kidney disease on glucose handling (including genetic defects).

Kidney international. Supplement·2011
Same journal

Need for better diabetes treatment for improved renal outcome.

Kidney international. Supplement·2011
Same journal

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

Kidney international. Supplement·2011
Same journal

SGLT2 inhibitors: molecular design and potential differences in effect.

Kidney international. Supplement·2011
Same journal

Glucose handling by the kidney.

Kidney international. Supplement·2011
Same journal

Bone: from a reservoir of minerals to a regulator of energy metabolism.

Kidney international. Supplement·2011
See all related articles

Many Mexicans with end-stage renal disease cannot access renal replacement therapy due to healthcare limitations. Mexico disproportionately uses peritoneal dialysis, with CAPD patients facing high risks from malnutrition and diabetes.

Area of Science:

  • Nephrology
  • Public Health
  • Socioeconomics

Background:

  • Mexico, despite a large economy, faces significant poverty impacting healthcare access.
  • End-stage renal disease affects an estimated 268 per million population.
  • Healthcare access is stratified by insurance, with 85% relying on government sources.

Purpose of the Study:

  • To examine the challenges and treatment modalities for end-stage renal disease in Mexico.
  • To highlight the impact of economic restrictions on renal replacement therapy.
  • To identify prevalent risk factors among patients undergoing peritoneal dialysis.

Main Methods:

  • Analysis of healthcare system data in Mexico.
  • Review of renal replacement therapy utilization rates.

Related Experiment Videos

  • Assessment of patient demographics and associated health risks.

    • Main Results:

    • Limited healthcare spending (5% of GNP) and economic restrictions on public institutions hinder renal replacement therapy.
    • Mexico utilizes peritoneal dialysis more than other countries (80% CAPD, 19% hemodialysis, 1% automated peritoneal dialysis).
    • Malnutrition and diabetes are common in Continuous Ambulatory Peritoneal Dialysis (CAPD) patients, posing risks.

    Conclusions:

    • Economic constraints significantly limit access to renal replacement therapy for Mexican patients.
    • The high reliance on CAPD in Mexico necessitates addressing prevalent malnutrition and diabetes.
    • Further research is needed to improve outcomes for Mexican ESRD patients.